以岭药业: 第八届监事会第十一次会议决议公告

Core Viewpoint - The company has approved the temporary use of part of the idle funds raised from a private placement to supplement its working capital, ensuring compliance with relevant regulations and not affecting ongoing investment projects [1][2]. Group 1: Meeting Details - The 11th meeting of the 8th Supervisory Board was held on July 11, 2025, with all three supervisors present for voting [1]. - The meeting was convened in accordance with the Company Law and the company's articles of association [1]. Group 2: Fund Usage Approval - The Supervisory Board approved the use of up to 150 million yuan of idle funds for temporary working capital, with a usage period not exceeding 12 months from the date of board approval [2]. - The voting results showed unanimous support, with 3 votes in favor and no opposition or abstentions [2].